Table 2.
Summary of the pharmacokinetic parameters for saquinavir obtained on day 14 with the different SQV-SGC regimens.
| Parameter | A 800 mg SQV-SGC | C 400:400 mg ritonavir:SQV-SGC | D 300:600 mg ritonavir:SQV-SGC | E 200:800 mg ritonavir:SQV-SGC | F 300:800 mg ritonavir:SQV-SGC | G 400:800 mg ritonavir:SQV-SGC | H 400:600 mg ritonavir:SQV-SGC | |
|---|---|---|---|---|---|---|---|---|
| Cmax(0,24 h) (µg ml−1) | Geometric mean | 0.53 | 2.92 | 3.94 | 4.52 | 5.78 | 5.06 | 4.78 |
| Range | 0.20–3.99 | 1.78–4.72 | 2.36–9.63 | 2.80–7.25 | 3.33–8.44 | 2.62–6.75 | 3.16–7.65 | |
| AUC(0,24 h) (µg ml−1 h) | Geometric mean | 3.03 | 30.92 | 41.93 | 52.17 | 65.21 | 67.72 | 58.93 |
| Range | 1.31–18.74 | 14.68–70.07 | 25.01–154.43 | 29.56–105.22 | 40.07–89.64 | 32.81–93.44 | 42.36–115.56 | |
| Cmin(0,24 h) (µg ml−1) | Geometric mean | 0.04 | 0.84 | 0.74 | 0.79 | 1.16 | 1.48 | 1.41 |
| Range | 0.02–0.12 | 0.32–1.71 | 0.22–2.70 | 0.43–2.68 | 0.50–1.66 | 0.65–2.88 | 0.86–4.32 | |
| t1/2 (h) | Harmonic mean | 9.6 | 6.0 | 6.4 | 5.4 | 4.8 | 5.4 | 5.5 |
| Geometric mean | 9.7 | 6.0 | 6.6 | 5.5 | 4.9 | 5.5 | 5.5 | |
| Range | 7.6–12.6 | 5.1–7.8 | 4.8–10.2 | 4.9–8.7 | 4.2–6.3 | 4.1–7.5 | 4.6–7.3 |